Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential [Corrigendum]
Chiricozzi A, De Simone C, Fossati B, Peris K. Psoriasis: Targets and Therapy. 2019;9:29–35.The authors of this paper have advised us that by mistake they uploaded the wrong figure files for Figures 2 and 3 which had not been correctly updated.Read the original article
Saved in:
Main Authors: | Chiricozzi A (Author), De Simone C (Author), Fossati B (Author), Peris K (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential
by: Chiricozzi A, et al.
Published: (2019) -
Bimekizumab for the treatment of moderate-to-severe plaque psoriasis: a meta-analysis of randomized clinical trials
by: Yuqian Wang, et al.
Published: (2023) -
An Overview of Bimekizumab for the Treatment of Psoriatic Arthritis: The Evidence so Far
by: G Oliveira D, et al.
Published: (2021) -
Eczematous eruption during bimekizumab treatment in a psoriatic patient previously treated with secukinumab
by: Gennaro Marco Falco, et al.
Published: (2024) -
Review of bimekizumab in the treatment of psoriasis
by: Sindhuja Koppu, et al.
Published: (2022)